Prevalence and correlates of depressive symptoms among high school adolescent girls in southern Uganda.
Adolescent girls
Depressive symptoms
Mental health
Prevalence
Uganda
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
25 Nov 2020
25 Nov 2020
Historique:
received:
13
04
2020
accepted:
19
11
2020
entrez:
26
11
2020
pubmed:
27
11
2020
medline:
24
3
2021
Statut:
epublish
Résumé
In sub-Saharan Africa (SSA), adolescent girls and young women are three times more likely than boys to have depressive disorders. Understanding adolescents' unique and common vulnerabilities and protective factors is essential for the development of appropriate interventions and programming focused on child and adolescent mental health. This paper examines the prevalence and predictors of depressive symptoms among high school adolescent girls in southern Uganda. Baseline data from a longitudinal cluster randomized study involving 1260 adolescent girls (14-17 years), recruited from 47 secondary schools were utilized. Depressive symptoms were estimated using the 21-item Beck's Depression Inventory. Hierarchical linear regression modelling was utilized to estimate key predictors of depressive symptoms among adolescent girls. Of the total sample, 16.35% (n = 206) reported severe depressive symptoms and almost one in every three adolescent girls interviewed (29.68%, n = 374) reported moderate symptoms. These symptoms were more prevalent among older adolescents (16 years and above). In addition, family relationships, social support, as well as measures of psychological wellbeing (self-concept and self-esteem) were all associated with lower levels of depressive symptoms. Hopelessness was associated with higher levels of depressive symptoms among adolescent girls. Findings from this study indicate a high prevalence of depressive symptoms, especially among older adolescent girls. In addition, family support factors and adolescents' psychological wellbeing were associated with low levels of depressive symptoms -pointing to the need to strengthen family functioning and adolescent's psychological wellbeing to mitigate risks. Taken together, findings support increasing calls for early screening and detection of depressive symptoms to facilitate timely referral to care and treatment. Findings may also inform the development and incorporation of gender-specific mental health components in programming targeting adolescent girls, in low-resource communities in SSA. This trial was prospectively registered with ClinicalTrials.gov (registration number: NCT03307226 ) on 11 October 2017.
Sections du résumé
BACKGROUND
BACKGROUND
In sub-Saharan Africa (SSA), adolescent girls and young women are three times more likely than boys to have depressive disorders. Understanding adolescents' unique and common vulnerabilities and protective factors is essential for the development of appropriate interventions and programming focused on child and adolescent mental health. This paper examines the prevalence and predictors of depressive symptoms among high school adolescent girls in southern Uganda.
METHODS
METHODS
Baseline data from a longitudinal cluster randomized study involving 1260 adolescent girls (14-17 years), recruited from 47 secondary schools were utilized. Depressive symptoms were estimated using the 21-item Beck's Depression Inventory. Hierarchical linear regression modelling was utilized to estimate key predictors of depressive symptoms among adolescent girls.
RESULTS
RESULTS
Of the total sample, 16.35% (n = 206) reported severe depressive symptoms and almost one in every three adolescent girls interviewed (29.68%, n = 374) reported moderate symptoms. These symptoms were more prevalent among older adolescents (16 years and above). In addition, family relationships, social support, as well as measures of psychological wellbeing (self-concept and self-esteem) were all associated with lower levels of depressive symptoms. Hopelessness was associated with higher levels of depressive symptoms among adolescent girls.
CONCLUSION
CONCLUSIONS
Findings from this study indicate a high prevalence of depressive symptoms, especially among older adolescent girls. In addition, family support factors and adolescents' psychological wellbeing were associated with low levels of depressive symptoms -pointing to the need to strengthen family functioning and adolescent's psychological wellbeing to mitigate risks. Taken together, findings support increasing calls for early screening and detection of depressive symptoms to facilitate timely referral to care and treatment. Findings may also inform the development and incorporation of gender-specific mental health components in programming targeting adolescent girls, in low-resource communities in SSA.
TRIAL REGISTRATION
BACKGROUND
This trial was prospectively registered with ClinicalTrials.gov (registration number: NCT03307226 ) on 11 October 2017.
Identifiants
pubmed: 33238965
doi: 10.1186/s12889-020-09937-2
pii: 10.1186/s12889-020-09937-2
pmc: PMC7689972
doi:
Banques de données
ClinicalTrials.gov
['NCT03307226']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1792Subventions
Organisme : NIMH NIH HHS
ID : R01 MH113486
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH118935
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH113486
Pays : United States
Références
BMC Public Health. 2018 Jun 5;18(1):693
pubmed: 29871619
Soc Psychiatry Psychiatr Epidemiol. 2003 Dec;38(12):715-9
pubmed: 14689176
Issues Ment Health Nurs. 2015 Mar;36(3):217-21
pubmed: 25897482
J Youth Adolesc. 2018 May;47(5):932-946
pubmed: 28785953
Soc Sci Med. 2006 Apr;62(7):1628-40
pubmed: 16169644
Soc Sci Med. 2005 Sep;61(5):943-64
pubmed: 15955397
BMC Public Health. 2012 Jul 23;12:541
pubmed: 22823941
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Psychol Health Med. 2011 May;16(3):346-56
pubmed: 21491342
J Adolesc Health. 2006 Sep;39(3):337-45
pubmed: 16919794
East Afr Med J. 2009 Jan;86(1):16-24
pubmed: 19530544
Child Care Health Dev. 2003 Sep;29(5):337-44
pubmed: 12904241
J Consult Clin Psychol. 1974 Dec;42(6):861-5
pubmed: 4436473
Trop Med Int Health. 2020 Jan;25(1):54-69
pubmed: 31698526
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
J Child Adolesc Ment Health. 2013;25(1):43-54
pubmed: 25860306
Vulnerable Child Youth Stud. 2019;14(4):351-363
pubmed: 32719723
S Afr Med J. 2013 Oct 11;103(12):910-5
pubmed: 24300627
Br J Psychiatry. 2016 Oct;209(4):284-293
pubmed: 27445355
Soc Sci Med. 2007 Jan;64(1):5-20
pubmed: 17045716
Psychol Bull. 2013 Jan;139(1):213-240
pubmed: 22730921
BJPsych Int. 2016 May 01;13(2):45-47
pubmed: 29093899
Child Youth Serv Rev. 2012 Jul;34(7):1351-1358
pubmed: 23188930
Lancet. 2012 Apr 28;379(9826):1641-52
pubmed: 22538179
BMC Psychiatry. 2012 Jun 18;12:63
pubmed: 22713589
Pediatrics. 2006 Jul;118(1):189-200
pubmed: 16818565
Afr J Psychiatry (Johannesbg). 2007 Nov;10(4):225-31
pubmed: 19588031
Child Adolesc Psychiatry Ment Health. 2013 Jul 10;7(1):21
pubmed: 23841918
Percept Mot Skills. 1980 Aug;51(1):157-8
pubmed: 7432952
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
J Psychiatry Neurosci. 2015 Jul;40(4):219-21
pubmed: 26107348
Am J Epidemiol. 2020 May 5;189(5):422-432
pubmed: 31667490
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
Arch Pediatr Adolesc Med. 2012 Mar;166(3):276-81
pubmed: 22393184
Glob Soc Welf. 2015 Jun;2(2):75-86
pubmed: 26146601
Pediatrics. 2015 Jul;136(1):128-40
pubmed: 26101362
Soc Sci Med. 2005 Aug;61(3):555-64
pubmed: 15899315
J Abnorm Psychol. 1998 Feb;107(1):128-40
pubmed: 9505045
J Community Psychol. 2019 Apr;47(3):579-593
pubmed: 30394541
Afr Health Sci. 2007 Dec;7(4):202-13
pubmed: 21499485
J Dev Behav Pediatr. 2013 Feb;34(2):129-37
pubmed: 23369959
J Adolesc. 2013 Aug;36(4):695-704
pubmed: 23849664
Child Adolesc Psychiatry Ment Health. 2019 Mar 11;13:14
pubmed: 30899327
J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):706-17
pubmed: 8056734
J Pers Soc Psychol. 2014 Feb;106(2):325-38
pubmed: 24467425
J Adolesc Health. 2006 Sep;39(3):456-8
pubmed: 16919815
AIDS Behav. 2013 Sep;17(7):2554-74
pubmed: 22972606
Prev Sci. 2016 Jan;17(1):134-43
pubmed: 26228480
Lancet. 2015 Nov 21;386(10008):2031-2032
pubmed: 26700380
AIDS Behav. 2020 Sep;24(9):2546-2554
pubmed: 32095914
Vulnerable Child Youth Stud. 2019;14(2):181-190
pubmed: 31149021
Front Psychol. 2016 Jun 28;7:982
pubmed: 27445941
Child Adolesc Psychiatry Ment Health. 2016 Oct 26;10:39
pubmed: 27800012
Soc Psychiatry Psychiatr Epidemiol. 2018 Feb;53(2):107-119
pubmed: 29234826
Afr Health Sci. 2019 Jun;19(2):1888-1896
pubmed: 31656472
Arch Gen Psychiatry. 2002 Mar;59(3):225-31
pubmed: 11879160
J Can Acad Child Adolesc Psychiatry. 2008 Aug;17(3):137-44
pubmed: 18769644
Trop Doct. 2020 Jan;50(1):30-36
pubmed: 31594531
Lancet Psychiatry. 2017 Feb;4(2):136-145
pubmed: 28137381
J Health Soc Behav. 2012;53(4):482-97
pubmed: 23197485
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
J Child Psychol Psychiatry. 2012 Apr;53(4):363-70
pubmed: 21883206
Br J Psychiatry. 1989 May;154:650-9
pubmed: 2597858
Soc Sci Med. 2009 Jul;69(2):191-8
pubmed: 19520472
J Abnorm Psychol. 1990 Feb;99(1):55-63
pubmed: 2307767
Healthc Policy. 2007 Feb;2(3):47-55
pubmed: 19305718
J Epidemiol Community Health. 2013 Mar;67(3):225-30
pubmed: 23410851
Electron Physician. 2017 Sep 25;9(9):5212-5222
pubmed: 29038699
BMC Cancer. 2019 May 17;19(1):466
pubmed: 31101016
AIDS Care. 2019 Oct;31(10):1297-1303
pubmed: 30621430
BMC Psychol. 2014 Mar 26;2(1):7
pubmed: 25566380
Soc Sci Med. 2019 May;228:17-24
pubmed: 30870668
Health Econ. 2010 Jul;19(7):855-71
pubmed: 19582699
J Psychol. 1978 Mar;98(2d Half):277-88
pubmed: 650597
J Adolesc Health. 1999 Aug;25(2):98-108
pubmed: 10447037
J Adolesc Health. 2014 Dec;55(6 Suppl):S31-8
pubmed: 25454000
J Pers Soc Psychol. 2016 Jan;110(1):e16-22
pubmed: 25915130
J Adolesc Health. 2012 Apr;50(4):346-52
pubmed: 22443837
J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):56-63
pubmed: 9893417